Suppr超能文献

川崎病中针对内皮细胞的抗体在无细胞因子预处理的情况下可溶解内皮细胞。

Antibodies to endothelial cells in Kawasaki disease lyse endothelial cells without cytokine pretreatment.

作者信息

Fujieda M, Oishi N, Kurashige T

机构信息

Department of Paediatrics, Kochi Medical School, Nankoku, Japan.

出版信息

Clin Exp Immunol. 1997 Jan;107(1):120-6. doi: 10.1046/j.1365-2249.1997.d01-894.x.

Abstract

Kawasaki disease (KD) is characterized by diffuse vasculitis and marked immune activation. To confirm the presence of antiendothelial cell antibodies (AECA) and cytotoxicity of AECA, we investigated the presence of AECA using ELISA and cytotoxicity of AECA in KD. Sera from patients with acute KD were assessed for binding to human umbilical vein endothelial cells (HUVEC) using a cell-based ELISA, and for cytotoxicity against HUVEC as indicated by the conversion of a tetrazolium salt (MTT) into a coloured product. IgM AECA were detected in 8/19 KD sera, IgG AECA were detected in 5/19 KD sera. Significant differences in both AECA titres existed between patients and febrile and afebrile controls. Six out of 19 patients showed complement-dependent cytotoxicity against HUVEC. Cytotoxicity was significantly enhanced by pretreating HUVEC with tumour necrosis factor (TNF), and reduced by incubation with gammaglobulin. Serum titres of IgM AECA in the KD patients were positively correlated with cytotoxicity. Findings suggest that IgM AECA mediates complement-dependent cytotoxicity against endothelial cells in patients with KD, and gammaglobulin may reduce complement-dependent cytotoxicity of AECA against endothelial cells.

摘要

川崎病(KD)的特征是弥漫性血管炎和显著的免疫激活。为了证实抗内皮细胞抗体(AECA)的存在以及AECA的细胞毒性,我们采用酶联免疫吸附测定(ELISA)研究了KD患者体内AECA的存在情况,并检测了AECA的细胞毒性。使用基于细胞的ELISA评估急性KD患者血清与人脐静脉内皮细胞(HUVEC)的结合情况,并通过四氮唑盐(MTT)转化为有色产物来检测血清对HUVEC的细胞毒性。在19份KD血清中,8份检测到IgM AECA,5份检测到IgG AECA。患者与发热及不发热对照之间的AECA滴度均存在显著差异。19例患者中有6例显示出对HUVEC的补体依赖性细胞毒性。用肿瘤坏死因子(TNF)预处理HUVEC可显著增强细胞毒性,而与丙种球蛋白孵育则可降低细胞毒性。KD患者的IgM AECA血清滴度与细胞毒性呈正相关。研究结果表明,IgM AECA介导KD患者体内对内皮细胞的补体依赖性细胞毒性,丙种球蛋白可能会降低AECA对内皮细胞的补体依赖性细胞毒性。

相似文献

引用本文的文献

4
Cytokine cascade in Kawasaki disease versus Kawasaki-like syndrome.川崎病与川崎病样综合征的细胞因子级联反应。
Physiol Res. 2022 Mar 25;71(1):17-27. doi: 10.33549/physiolres.934672. Epub 2022 Jan 19.
5
Antibodies and Immunity During Kawasaki Disease.川崎病期间的抗体与免疫
Front Cardiovasc Med. 2020 May 28;7:94. doi: 10.3389/fcvm.2020.00094. eCollection 2020.
6
B Cells and Antibodies in Kawasaki Disease.川崎病中的 B 细胞和抗体。
Int J Mol Sci. 2019 Apr 13;20(8):1834. doi: 10.3390/ijms20081834.
7
PGK1 as an immune target in Kawasaki disease.PGK1 作为川崎病的免疫治疗靶点。
Clin Exp Immunol. 2018 Dec;194(3):371-379. doi: 10.1111/cei.13204. Epub 2018 Oct 15.
8
Antibody Profiling of Kawasaki Disease Using Proteome Microarrays.川崎病的蛋白质组微阵列抗体分析。
Mol Cell Proteomics. 2018 Mar;17(3):472-481. doi: 10.1074/mcp.RA117.000198. Epub 2017 Dec 15.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验